No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Celldex Therapeutics(CLDX.US) Officer Sells US$608.31K in Common Stock
Celldex Therapeutics(CLDX.US) Officer Sells US$1.05 Million in Common Stock
Stifel Starts Celldex at Buy, Sees Lead Drug as Potential Blockbuster
Express News | Cantor Fitzgerald Reiterates Overweight on Celldex Therapeutics, Maintains $67 Price Target
Express News | Celldex Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $58
Stifel Initiates Celldex Therapeutics(CLDX.US) With Buy Rating, Announces Target Price $58